\documentclass[11pt,twoside]{article}\makeatletter \IfFileExists{xcolor.sty}% {\RequirePackage{xcolor}}% {\RequirePackage{color}} \usepackage{colortbl} \usepackage{wrapfig} \usepackage{ifxetex} \ifxetex \usepackage{fontspec} \usepackage{xunicode} \catcode`⃥=\active \def⃥{\textbackslash} \catcode`❴=\active \def❴{\{} \catcode`❵=\active \def❵{\}} \def\textJapanese{\fontspec{Noto Sans CJK JP}} \def\textChinese{\fontspec{Noto Sans CJK SC}} \def\textKorean{\fontspec{Noto Sans CJK KR}} \setmonofont{DejaVu Sans Mono} \else \IfFileExists{utf8x.def}% {\usepackage[utf8x]{inputenc} \PrerenderUnicode{–} }% {\usepackage[utf8]{inputenc}} \usepackage[english]{babel} \usepackage[T1]{fontenc} \usepackage{float} \usepackage[]{ucs} \uc@dclc{8421}{default}{\textbackslash } \uc@dclc{10100}{default}{\{} \uc@dclc{10101}{default}{\}} \uc@dclc{8491}{default}{\AA{}} \uc@dclc{8239}{default}{\,} \uc@dclc{20154}{default}{ } \uc@dclc{10148}{default}{>} \def\textschwa{\rotatebox{-90}{e}} \def\textJapanese{} \def\textChinese{} \IfFileExists{tipa.sty}{\usepackage{tipa}}{} \fi \def\exampleFont{\ttfamily\small} \DeclareTextSymbol{\textpi}{OML}{25} \usepackage{relsize} \RequirePackage{array} \def\@testpach{\@chclass \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else \ifnum \@lastchclass=7 5 \else \ifnum \@lastchclass=8 \tw@ \else \ifnum \@lastchclass=9 \thr@@ \else \z@ \ifnum \@lastchclass = 10 \else \edef\@nextchar{\expandafter\string\@nextchar}% \@chnum \if \@nextchar c\z@ \else \if \@nextchar l\@ne \else \if \@nextchar r\tw@ \else \z@ \@chclass \if\@nextchar |\@ne \else \if \@nextchar !6 \else \if \@nextchar @7 \else \if \@nextchar (8 \else \if \@nextchar )9 \else 10 \@chnum \if \@nextchar m\thr@@\else \if \@nextchar p4 \else \if \@nextchar b5 \else \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi} \gdef\arraybackslash{\let\\=\@arraycr} \def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}} \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \def\abbr{} \def\corr{} \def\expan{} \def\gap{} \def\orig{} \def\reg{} \def\ref{} \def\sic{} \def\persName{}\def\name{} \def\placeName{} \def\orgName{} \def\textcal#1{{\fontspec{Lucida Calligraphy}#1}} \def\textgothic#1{{\fontspec{Lucida Blackletter}#1}} \def\textlarge#1{{\large #1}} \def\textoverbar#1{\ensuremath{\overline{#1}}} \def\textquoted#1{‘#1’} \def\textsmall#1{{\small #1}} \def\textsubscript#1{\@textsubscript{\selectfont#1}} \def\textxi{\ensuremath{\xi}} \def\titlem{\itshape} \newenvironment{biblfree}{}{\ifvmode\par\fi } \newenvironment{bibl}{}{} \newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par } \newenvironment{citbibl}{}{\ifvmode\par\fi } \newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi } \newenvironment{docDate}{}{\ifvmode\par\fi } \newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi } \newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par } \newenvironment{msHead}{\vskip 6pt}{\par} \newenvironment{msItem}{\vskip 6pt}{\par} \newenvironment{rubric}{}{} \newenvironment{titlePart}{}{\par } \newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}} \newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}} \newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}} \newcolumntype{P}[1]{){\arraybackslash}p{#1}} \newcolumntype{B}[1]{){\arraybackslash}b{#1}} \newcolumntype{M}[1]{){\arraybackslash}m{#1}} \definecolor{label}{gray}{0.75} \def\unusedattribute#1{\sout{\textcolor{label}{#1}}} \DeclareRobustCommand*{\xref}{\hyper@normalise\xref@} \def\xref@#1#2{\hyper@linkurl{#2}{#1}} \begingroup \catcode`\_=\active \gdef_#1{\ensuremath{\sb{\mathrm{#1}}}} \endgroup \mathcode`\_=\string"8000 \catcode`\_=12\relax \usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry} \usepackage{framed} \definecolor{shadecolor}{gray}{0.95} \usepackage{longtable} \usepackage[normalem]{ulem} \usepackage{fancyvrb} \usepackage{fancyhdr} \usepackage{graphicx} \usepackage{marginnote} \renewcommand{\@cite}[1]{#1} \renewcommand*{\marginfont}{\itshape\footnotesize} \def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif} \pagestyle{fancy} \usepackage[pdftitle={Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques}, pdfauthor={}]{hyperref} \hyperbaseurl{} \paperwidth210mm \paperheight297mm \def\@pnumwidth{1.55em} \def\@tocrmarg {2.55em} \def\@dotsep{4.5} \setcounter{tocdepth}{3} \clubpenalty=8000 \emergencystretch 3em \hbadness=4000 \hyphenpenalty=400 \pretolerance=750 \tolerance=2000 \vbadness=4000 \widowpenalty=10000 \renewcommand\section{\@startsection {section}{1}{\z@}% {-1.75ex \@plus -0.5ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large\bfseries}} \renewcommand\subsection{\@startsection{subsection}{2}{\z@}% {-1.75ex\@plus -0.5ex \@minus- .2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large}} \renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}% {-1.5ex\@plus -0.35ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\large}} \renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}% {-1ex \@plus-0.35ex \@minus -0.2ex}% {0.5ex \@plus .2ex}% {\reset@font\normalsize}} \renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}% {1.5ex \@plus1ex \@minus .2ex}% {-1em}% {\reset@font\normalsize\bfseries}} \def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt} \@tempdima 1.5em \begingroup \parindent \z@ \rightskip \@pnumwidth \parfillskip -\@pnumwidth \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par \endgroup} \def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}} \def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}} \def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}} \def\l@subparagraph{\@dottedtocline{5}{10em}{5em}} \@ifundefined{c@section}{\newcounter{section}}{} \@ifundefined{c@chapter}{\newcounter{chapter}}{} \newif\if@mainmatter \@mainmattertrue \def\chaptername{Chapter} \def\frontmatter{% \pagenumbering{roman} \def\thechapter{\@roman\c@chapter} \def\theHchapter{\roman{chapter}} \def\thesection{\@roman\c@section} \def\theHsection{\roman{section}} \def\@chapapp{}% } \def\mainmatter{% \cleardoublepage \def\thechapter{\@arabic\c@chapter} \setcounter{chapter}{0} \setcounter{section}{0} \pagenumbering{arabic} \setcounter{secnumdepth}{6} \def\@chapapp{\chaptername}% \def\theHchapter{\arabic{chapter}} \def\thesection{\@arabic\c@section} \def\theHsection{\arabic{section}} } \def\backmatter{% \cleardoublepage \setcounter{chapter}{0} \setcounter{section}{0} \setcounter{secnumdepth}{2} \def\@chapapp{\appendixname}% \def\thechapter{\@Alph\c@chapter} \def\theHchapter{\Alph{chapter}} \appendix } \newenvironment{bibitemlist}[1]{% \list{\@biblabel{\@arabic\c@enumiv}}% {\settowidth\labelwidth{\@biblabel{#1}}% \leftmargin\labelwidth \advance\leftmargin\labelsep \@openbib@code \usecounter{enumiv}% \let\p@enumiv\@empty \renewcommand\theenumiv{\@arabic\c@enumiv}% }% \sloppy \clubpenalty4000 \@clubpenalty \clubpenalty \widowpenalty4000% \sfcode`\.\@m}% {\def\@noitemerr {\@latex@warning{Empty `bibitemlist' environment}}% \endlist} \def\tableofcontents{\section*{\contentsname}\@starttoc{toc}} \parskip0pt \parindent1em \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \newenvironment{reflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemsep}{0pt}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\itshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{sansreflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\itemsep}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\upshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{specHead}[2]% {\vspace{20pt}\hrule\vspace{10pt}% \phantomsection\label{#1}\markright{#2}% \pdfbookmark[2]{#2}{#1}% \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}% }{} \def\TheFullDate{2017-01-15 (revised: 15 January 2017)} \def\TheID{\makeatother } \def\TheDate{2017-01-15} \title{Circulating Progesterone Levels and Ongoing Pregnancy Rates in Controlled Ovarian Stimulation Cycles in Assisted Reproduction Techniques} \author{}\makeatletter \makeatletter \newcommand*{\cleartoleftpage}{% \clearpage \if@twoside \ifodd\c@page \hbox{}\newpage \if@twocolumn \hbox{}\newpage \fi \fi \fi } \makeatother \makeatletter \thispagestyle{empty} \markright{\@title}\markboth{\@title}{\@author} \renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@ \belowdisplayskip \abovedisplayskip \abovedisplayshortskip \z@ plus2\p@ \belowdisplayshortskip 4\p@ plus2\p@ minus2\p@ \def\@listi{\leftmargin\leftmargini \topsep 2\p@ plus1\p@ minus1\p@ \parsep 2\p@ plus\p@ minus\p@ \itemsep 1pt} } \makeatother \fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm} \fancyhf{} \setlength{\headheight}{14pt} \fancyhead[LE]{\bfseries\leftmark} \fancyhead[RO]{\bfseries\rightmark} \fancyfoot[RO]{} \fancyfoot[CO]{\thepage} \fancyfoot[LO]{\TheID} \fancyfoot[LE]{} \fancyfoot[CE]{\thepage} \fancyfoot[RE]{\TheID} \hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true} \fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}} \date{} \usepackage{authblk} \providecommand{\keywords}[1] { \footnotesize \textbf{\textit{Index terms---}} #1 } \usepackage{graphicx,xcolor} \definecolor{GJBlue}{HTML}{273B81} \definecolor{GJLightBlue}{HTML}{0A9DD9} \definecolor{GJMediumGrey}{HTML}{6D6E70} \definecolor{GJLightGrey}{HTML}{929497} \renewenvironment{abstract}{% \setlength{\parindent}{0pt}\raggedright \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt \textcolor{GJBlue}{\large\bfseries\abstractname\space} }{% \vskip8pt \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt } \usepackage[absolute,overlay]{textpos} \makeatother \usepackage{lineno} \linenumbers \begin{document} \author[1]{Shailja Verma} \author[2]{Pratap Kumar} \affil[1]{ Kingston Hospital, NHS, London, UK} \renewcommand\Authands{ and } \date{\small \em Received: 9 December 2016 Accepted: 3 January 2017 Published: 15 January 2017} \maketitle \begin{abstract} How can we prevent premature leutinization in our IVF cycles? To help find the solution a study designed with specific exclusion criteria in an assisted reproductive centre of a tertiary care hospital was designed. In a period of 2 years 100 patients were followed up prospectively. GnRH antagonist protocol was implemented for all recruits because of shorter duration of treatment and as it prevented hyperstimulation. Specific criteria was chosen for GnRH anatagonist initiation. Serum Progesterone measurements were used to predict premature leutinization. Electro-chemiluminiscence Immunoassay using COBAS 6000 used for the measurements. Three different groups analysed in above cohort and we concluded that despite of progesterone rise pregnancy outcome was unaffected. Why is the question answered in discussion. \end{abstract} \keywords{GnRH (gonadotropin releasing hormone), progesterone, IVF, leutinization.} \begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) \textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark} \end{textblock*} \begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) \textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}} \end{textblock*} \let\tabcellsep& \section[{I. Introduction}]{I. Introduction}\par ne of the essential components of a successful in vitro fertilization/embryo transfer (IVF -ET) cycles is the procurement of mature oocytes that will develop into good embryos with good implantation potential. There are a variety of ovulation induction protocols being utilized to achieve this goal but the markers of optimal maturity remain controversial.\par The progesterone increase at, or just before, the onset of LH surge, was thought to be the response of granulosa cells to increased pituitary LH pulses. On the other hand, progesterone can also augment the positive feedback of estradiol on the LH surge \hyperref[b0]{1} . During controlled ovarian stimulation (COS) cycle, progesterone levels rapidly increase following Human Chorionic Gonadotropin (hCG) administration given to induce final oocyte maturation \hyperref[b1]{2} . However, we have also noticed premature LH (Leutinizing hormone) surge caused by the modulatory action of estradiol (E2) levels induced by gonadotropins which have led to premature luteinization and further more cancellation of treatment cycles in patients who are undergoing in vitro fertilization O gonadotropins from pituitary by introduction of Gonadotropin releasing hormone (GnRH) agonists and antagonists which can decrease incidence of premature LH surge \hyperref[b1]{2} . Despite use of GnRH analogues, subtle increase in serum progesterone levels (beyond an arbitrary threshold value) have been observed at the end of follicular phase in stimulation cycles for IVF and ICSI -ET \hyperref[b2]{3} .\par This pre-hCG progesterone increase is referred as 'premature luteinization' \hyperref[b3]{4} , the term though is misleading as the increasing levels of serum progesterone occurs with GnRH analogues, i.e. it is taking place under low serum LH concentration.\par Rather than the excessive amount of progesterone being produced by granulosa cells as a part of early luteinization, it is more likely that excess number of follicles are responsible for elevated progesterone levels as each one may be producing a normal amount of progesterone, consistent with late follicular phase \hyperref[b4]{5} . Whether the presence of increased levels of progesterone on the day of hCG will affect ongoing pregnancy rate is the subject of debate.\par Hence, we have investigated association between serum progesterone levels on the day of human Chorionic Gonadotropin (hCG) administration and the probability of ongoing pregnancy in woman undergoing Controlled Ovarian Stimulation for IVF (in vitro fertilization)/ICSI-ET (Intracytoplasmic sperm injection with Embryo transfer) in our this study. \section[{II. METHODOLOGY}]{II. METHODOLOGY}\par This prospective single center study was done under the ethical guidelines of our institution. A total of 100 patients were included meeting the above criteria and received GnRH antagonist protocol for pituitary down regulation. Study period was of 2 years. Cases of endometriosis and women with above 35 years of age were excluded. The initial dose of gonadotropins was individualized for each patient according to age, BMI, basal FSH levels, antral follicle count and previous response to controlled ovarian stimulation. Dose adjustments performed according to ovarian response, monitored by TVS \& serum E2 levels. As a part of routine (IVF). We can now suppress the release of endogenous clinical practice, determination of serum progesterone levels were performed on the day of hCG administration. a) Progesterone measurement Laboratory measurement of serum progesterone was done using electrochemiluminiscence Immunoassay "ELISA" using COBAS 6000. Results are determined via a calibration curve which is instrument -specifically generated by 2point calibration \& a master curve provided via the reagent barcode. Quality control using Elecsys Preci Control Universal 1 and 2 are done at least once in 24 hours when test is in use, once per reagent kit, and after every calibration. Measuring range is 0.030 -60.00 ng/ml. For purpose of statistical analysis serum progesterone was divided into 3 categories as follows: a) <1 ng/ml b)1-1.5 ng/ml c) >1.5 ng/ml. \section[{b) Statistical analysis}]{b) Statistical analysis}\par The analysis was performed using SPSS version 16 software. The statistical analysis of the data was performed using Pearson Chi -square test or Fischer Exact test. p -value of < 0.05 was considered significant. \section[{c) Results}]{c) Results}\par Three groups were formed as described above. The results were compared with the levels of progesterone on the day of hCG administration in stimulation cycle with various outcomes as described below. Baseline characteristics of 100 cases were comparable in all the three groups. Outcomes were measured in terms of total number of mature eggs; quality of embryos; pregnancy outcomes.\par Out of 93 women who had less than 1 ng/ml serum progesterone on day of menses, 64.5 \% remained less than 1 ng/ml on the day of hCG, 21.5 \% it was raised to 1-1.5 ng/ml and in 14 \% to >1.5 ng/ml. Three women who had 1-1.5 ng/ml had equal proportion on the day of hCG whereas those who had more than 1.5 ng/ml of progesterone on day 2 of cycle (n = 4) had equal proportion in 1-1.5 ng/ml \& more than 1.5 ng/ml. This shows that most of the women show a rise in levels of progesterone on the day of hCG (0.022).\par Out of 61 women 59\% had estradiol levels less than 3000 pg/ml, 32.8 \% had estradiol levels in 3000-6000 pg/ml \& 8.2 \% had estradiol levels >6000 pg/ml, whereas in group with 1-1.5 ng/ml and more than 1.5 ng/ml progesterone only 4.3 \% \& 6.2 \% women had estradiol more than 6000 pg/ml. Though there is a positive correlation between rising estradiol levels and progesterone levels, this was not seen in this study (Table {\ref 1}). We saw good endometrial thickness in all three groups irrespective of serum progesterone levels.\par Table {\ref 1}: Comparing serum progesterone levels on the day of hCG with serum Estradiol level.\par (P value is 0.92 by applying Fischer's Exact Test, hence not statistically significant)\par In terms of retrieving good mature eggs also we see that out of 61 women with serum progesterone less than 1 ng/ml 78.7\% had up to 8 mature eggs, 18\% had 9-16 mature eggs whereas 3.3\% had more than 16 mature eggs. In women with 1-1.5 ng/ml progesterone (n = 23) 56.5\% had less than 8 mature eggs \& rest 43.5\% had 9-16 mature eggs, whereas out of 16 women with more than 1.5 ng/ml progesterone, 62.5\% had up to 8 mature eggs whereas 31.5\% had 9-16 mature eggs \& 6.2\% had more than 16 mature eggs.\par Hence we see that good numbers of mature eggs were retrieved in equal proportion in all the three categories ( Sixty one women had progesterone levels less than 1 ng/ml, out of them 26.2\% had no best grade embryos retrieved 39.3\% had up to 2 \& 34.4\% had more than 3 best grade embryos. In comparison, group with 1-1.5 ng/ml progesterone 17.4\% had no embryos, 39.1\% had up to 2 \& 43.5\% had more than 3 best grade embryos.\par Finally, out of 16 women with more than 1.5 ng/ml progesterone 25\% had no best embryos, 43.8\% had up to 2 and 31.2\% had more than 3 best embryos. Hence, best grade embryos were retrieved in equal proportion in all groups (Table \hyperref[tab_2]{3}). Ninety one cases came for follow up beta hCG testing to us out of them 41.8\% were pregnant. We further followed these pregnant cases, 71\% of these pregnant women had their first antenatal scan done with us showing cardiac activity present.\par Three cases were chemical pregnancy whereas other 3 cases had ectopic pregnancies (Table \hyperref[tab_3]{4}). In the group with progesterone levels > 1.5 ng/ml 40\% patient became pregnant \& 60\% patients were non pregnant, though statistically not significant we followed up these cases \& compared their serum progesterone levels with their pregnancy outcome by the first trimester scan for presence of cardiac activity, excluding chemical pregnancy.\par Progesterone estradiol ratio >1 as the definition of premature luteinization was proposed to be associated with low ovarian reserve as well as poor pregnancy outcomes in some studies \hyperref[b5]{6} .\par Hence we found that though pregnancy outcome is higher in groups with ratio <1 but this difference was not statistically significant (Table \hyperref[tab_4]{5}). \section[{III. DISCUSSION}]{III. DISCUSSION}\par Several mechanisms have been proposed to explain subtle elevation of progesterone on the day of hCG administration. It has been suggested that excessive luteinization of the follicles occurs either due to late administration of hCG or exposure of granulosa cells to high concentration of LH forms, exogenous gonadotropin treatment \hyperref[b6]{7,}\hyperref[b7]{8} . Both of them seem unlikely in our set up as GnRH antagonist protocol was used and no premature LH surge or decline in estradiol was seen post hCG administration. Also, good fertilization rates are contradictory to excessive luteinization explanation. Another explanation is that follicle maturation may occur at a lower follicle diameter than expected, resulting in post-mature oocytes. However, hCG administration decision was not based solely on ultrasound findings; furthermore, no adverse effect was reported on the maturation phase of the oocytes, or fertilization or cleavage rates of embryos in the group with higher progesterone levels on the day of hCG administration \hyperref[b8]{9} .\par However, treatment with GnRH antagonists has been reported to suppress both immuno-active and bioactive LH but not the subtle rise in progesterone on day of hCG administration {\ref 10.} Small elevation in progesterone levels on the day of hCG is not caused by elevation of LH because of higher pituitary output or external stimulation rather it may likely because of a local increase from the ovaries and an increase in receptivity of LH at the level of granulosa cells. There are also other intra-ovarian regulators which can be involved in the regulation of ovarian steroidogenesis \hyperref[b10]{11} , and also there is somatomedin-C which is found to augment significantly FSH induced progesterone biosynthesis in the rat in vitro culture \hyperref[b11]{12} .\par Our results have shown no difference in serum estradiol levels on the day of hCG, irrespective of higher or lower progesterone levels; none of our cases had significant premature LH surge; the number of oocytes recruited and their fertilization \& cleavage rates did not differ between the three groups that we took in this study.\par The possibility that small changes in the progesterone levels, on the day of hCG, may primarily effect the endometrium rather than on the ovary has already been proposed. An abnormal rise of progesterone prior to LH surge was reported to affect the uterine endometrium and it results in asynchronization between embryonic development and the endometrial environment \hyperref[b11]{12} .\par The hormonal receptors present in the endometrium may be affected and may influence other factors responsible for implantation, like platelet activating factor (PAF), one of the factors reported to be involved in the process of implantation \hyperref[b12]{13} .\par In a study of 115 cases, IVF/ET cycle outcomes were retrospectively correlated with progesterone levels on the day of hCG, as findings demonstrated that even modest increase in progesterone was associated with reduced pregnancy rates. So they recommended to cryopreserve all embryos rather than having a fresh embryo transfer \hyperref[b13]{14} . Other changes in clinical practice may include administrating hCG at a smaller follicle size if progesterone levels start rising.\par We require more studies to define the optimal markers of follicle maturation facilitating better timing of hCG administration \hyperref[b14]{15} .\par In a study on one thousand twelve women undergoing 1,189 IVF-ET cycles, Fanchin et al demonstrated that when there is an adequately required response to controlled ovarian stimulation, an elevated P levels are not associated with lower pregnancy outcomes. This indicates that good embryo quality may compensate for the adverse endometrial effects of progesterone but when there is a weak response to controlled ovarian stimulation (poor responders), premature elevation can lead to lower pregnancy rates \hyperref[b16]{16} .\par The cause of increase in serum progesterone levels is poorly understood. It may just reflect the mature granulosa cell response to high FSH exposure. It can be a possibility that the gonadotropin used in the stimulation regimen and the amount of LH suppression may play a role in the phenomenon, as both FSH \& LH activity may differ in both quality \& quantity between products and batches seperately.\par Ubaldi et al showed some results indicating that there may be an association between the circulating FSH concentration an late follicular phase progesterone concentrations. This observation can lead to an alternate hypothesis for the increased progesterone secretion in the cycles which are treated with purified FSH \hyperref[b15]{17} . It is also possible that reduced LH stimulation reduces the degree of catabolism of progesterone to androgens \& estrogens, as reported above, which leads to excess progesterone secretion into the circulation.\par Fleming in his study also raised the issue of methodology used for measuring progesterone in the studies, retained in meta -analysis, which were neither conceived nor validated for measuring low levels of progesterone in the follicular phase \hyperref[b18]{18} . His own data showed that assay precision was varying depending on whether petrol -ether extraction step was used or not sufficiently supports this methodology concern. Also he provided with the evidence supporting the possibility that progesterone measurements at the end of controlled ovarian treatments could be flawed by patient specific matrix effects \hyperref[b18]{18} . The method used in our study had a strict inclusion and exclusion criteria for case selection and the method used for progesterone measurement had a good precision hence unlikely that results are affected by above raised issue.\par In Bosch et al study, the strength of association observed might be attenuated by the method used to group patients according to progesterone levels because their assay had sensitivity of 0.2 ng/ml, whereas assay used in this study has sensitivity of 0.030 ng/ml \hyperref[b19]{19} .\par At present we have no consensus on whether the elevation of progesterone on day of hCG is associated with achieving of a pregnancy. Several studies have denied such association \hyperref[b3]{4,}\hyperref[b19]{19,}\hyperref[b20]{20,}\hyperref[b21]{21} , whereas other studies have concluded possibility of a negative association that is probability of pregnancy decreasing significantly when progesterone levels on the day of hCG for final oocyte maturation, rises above a threshold 7, 16, 22 . In this study we noted that there is no association between elevation of progesterone on the day of hCG administration and pregnancy rate. It should be noted that if negative association between progesterone elevation on day of hCG and the chances of pregnancy do exists, it might be worth exploring the possibility of cryopreserving the resulting embryos and they can be transferred in a subsequent frozen -thawed cycle \hyperref[b23]{23,}\hyperref[b13]{14} or another alternative is administrating hCG early in the follicular phase prior to progesterone elevation \hyperref[b18]{18} .\par Different detrimental levels of serum progesterone on day of hCG in terms of pregnancy outcome has been proposed by above mentioned studies but in this study no such level could be indentified as in all cases we had good response to controlled ovarian stimulation protocol.\par Limitation of this study was less sample size hence results were not statistically significant and larger studies size is required.\par We found that though there is a rise in serum progesterone seen during controlled ovarian stimulation cycles on the day of hCG in GnRH antagonist cycle but this rise has no significant effect on endometrium thickness, number \& quality of oocytes retrieved, number \& quality of embryos retrieved and finally pregnancy outcome.\begin{figure}[htbp] \noindent\textbf{2} \par \begin{longtable}{P{0.85\textwidth}} Volume XVII Issue I Version I\\ D D D D ) E\\ (\\ Medical Research\\ Global Journal of\end{longtable} \par \caption{\label{tab_0}Table 2 )}\end{figure} \begin{figure}[htbp] \noindent\textbf{2} \par \begin{longtable}{} \end{longtable} \par {\small\itshape [Note: (P value is 0.10 by applying Fischer's Exact Test, hence not statistically significant)]} \caption{\label{tab_1}Table 2 :}\end{figure} \begin{figure}[htbp] \noindent\textbf{3} \par \begin{longtable}{P{0.3742798353909465\textwidth}P{0.02448559670781893\textwidth}P{0.010493827160493826\textwidth}P{0.04897119341563786\textwidth}P{0.13991769547325103\textwidth}P{0.04897119341563786\textwidth}P{0.027983539094650206\textwidth}P{0.09794238683127572\textwidth}P{0.07695473251028807\textwidth}} Serum progesterone on the day of hCG\tabcellsep n\tabcellsep Nil\tabcellsep \%\tabcellsep \multicolumn{2}{l}{Best embryos retreived Upto 2 n \%}\tabcellsep n\tabcellsep More than 3 \%\tabcellsep Total (n=100)\\ <1 ng/ml (n = 61)\tabcellsep 16\tabcellsep \tabcellsep 26.2\tabcellsep 24\tabcellsep 39.3\tabcellsep 21\tabcellsep 34.4\tabcellsep 61\\ 1-1.5 ng/ml (n = 23)\tabcellsep 4\tabcellsep \tabcellsep 17.4\tabcellsep 9\tabcellsep 39.1\tabcellsep 10\tabcellsep 43.5\tabcellsep 23\\ >1.5 ng/ml (n = 16)\tabcellsep 4\tabcellsep \tabcellsep 25\tabcellsep 7\tabcellsep 43.8\tabcellsep 5\tabcellsep 31.2\tabcellsep 16\\ Total (n = 100)\tabcellsep 24\tabcellsep \tabcellsep 24\tabcellsep 40\tabcellsep 40\tabcellsep 36\tabcellsep 36\tabcellsep 100\end{longtable} \par \caption{\label{tab_2}Table 3 :}\end{figure} \begin{figure}[htbp] \noindent\textbf{4} \par \begin{longtable}{} \end{longtable} \par \caption{\label{tab_3}Table 4 :}\end{figure} \begin{figure}[htbp] \noindent\textbf{5} \par \begin{longtable}{P{0.4573099415204678\textwidth}P{0.03728070175438596\textwidth}P{0.0695906432748538\textwidth}P{0.049707602339181284\textwidth}P{0.10935672514619882\textwidth}P{0.02982456140350877\textwidth}P{0.0969298245614035\textwidth}} Serum progesterone\tabcellsep Pregnant\tabcellsep \tabcellsep \tabcellsep Non pregnant\tabcellsep \tabcellsep Total\\ on the day of hCG\tabcellsep n\tabcellsep \%\tabcellsep n\tabcellsep \%\tabcellsep \tabcellsep (n = 91)\\ <1 ng/ml (n = 56)\tabcellsep 26\tabcellsep 46.4\tabcellsep 30\tabcellsep 53.6\tabcellsep \tabcellsep 56\\ 1-1.5 ng/ml (n = 20)\tabcellsep 6\tabcellsep 30\tabcellsep 14\tabcellsep 70\tabcellsep \tabcellsep 20\\ >1.5 ng/ml (n = 15)\tabcellsep 6\tabcellsep 40\tabcellsep 9\tabcellsep 60\tabcellsep \tabcellsep 15\\ Total (n = 91)\tabcellsep 38\tabcellsep 41.8\tabcellsep 53\tabcellsep 58.2\tabcellsep \tabcellsep 91\\ \multicolumn{2}{l}{Progesterone estrogen ratio}\tabcellsep Pregnant\tabcellsep \tabcellsep \multicolumn{2}{l}{Non pregnant}\tabcellsep Total\\ \multicolumn{2}{l}{on the day of hCG}\tabcellsep n\tabcellsep \%\tabcellsep n\tabcellsep \%\tabcellsep (n = 91)\\ <1 (n = 84)\tabcellsep \tabcellsep 37\tabcellsep 44\tabcellsep 47\tabcellsep 56\tabcellsep 84\\ >1 (n = 7)\tabcellsep \tabcellsep 1\tabcellsep 14.3\tabcellsep 6\tabcellsep 85.7\tabcellsep 7\\ Total (n = 91)\tabcellsep \tabcellsep 38\tabcellsep 41.8\tabcellsep 53\tabcellsep 58.2\tabcellsep 91\end{longtable} \par \caption{\label{tab_4}Table 5 :}\end{figure} \footnote{© 2017 Global Journals Inc. (US)} \footnote{© 2017 Global Journals Inc. (US)Year 2017} \backmatter \begin{bibitemlist}{1} \bibitem[Dirnfeld et al. ()]{b8}\label{b8} ‘A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization -embryo transfer patients’. M Dirnfeld , S Goldman , Y Gonen , M Koifman , A Lissak , H Abramovic . \textit{J Assist Repro Genet} 1993. 10 (2) p. . \bibitem[Harada et al. ()]{b22}\label{b22} ‘Altering the timing of human chorionic gonadotropin injection according to serum progesterone (P) concentrations improves embryo quality in cycles with subtle P rise’. T Harada , C Katagiri , N Takao , T Toda , Y Mio , N Terakawa . \textit{Fertil Steril} 1996. 65 p. . \bibitem[Bosch et al. ()]{b19}\label{b19} ‘Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles’. E Bosch , E Labarta , J Crespo , C Simon , J Remohi , J Jenkins , A Pellicer . \textit{Hum Reprod} 2010. 25 p. . \bibitem[Fanchin et al. ()]{b16}\label{b16} ‘Consequences of premature progesterone elevation on the outcome of in vitro fertilization: Insights into a controversy’. R Fanchin , C Righini , F Olivennes , A L Ferreira , R De Ziegler D, Frydman . \textit{Fertil Steril} 1997b. 68 p. . \bibitem[Urman et al. ()]{b20}\label{b20} ‘Elevated serum progesterone level on the day of hCG does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo tranfer’. B Urman , C Alatas , S Aksoy , R Mercan , A Isiklar , B Balaban . \textit{Fertil Steril} 1999. 72 p. . \bibitem[Doldi et al. ()]{b21}\label{b21} ‘Elevated serum progesterone on the day of hCG administation in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome’. N Doldi , E Marsiglio , A Destafani , A Gessi , G Merati , A Ferrari . \textit{Hum Reprod} 1999. 14 p. . \bibitem[Spinks et al. ()]{b12}\label{b12} ‘Embryo derived platelet activating factor is essential in establishment of pregnancy in the mouse’. N R Spinks , C O'neill , M Collier , J P Ryan . \textit{Lancet} 1987. 1 p. 106. \bibitem[Jones ()]{b11}\label{b11} ‘Factors influencing implantation and maintenence of pregnancy following embryo transfer’. H W Jones . \textit{Fertilization of the Human in vitro}, Hm, Beiber, Linder (ed.) (Berlin) 1985. Springer-Verlag. p. 293. \bibitem[Hoff et al. ()]{b0}\label{b0} ‘Hormonal dynamics mid cycle: A reevaluation’. T D Hoff , M E Quigley , Ssc Yen . \textit{J Clin Endocrinol Metab} 1983. 57 p. . \bibitem[Halbersztadt et al. ()]{b2}\label{b2} ‘Implantation and antigenicity of human endometrium’. A Halbersztadt , J Pajak , P Nowicki , I Ja?ocha . \textit{Postepy Hig Med Dosw} 2006. 60 p. . \bibitem[Younis et al. ()]{b5}\label{b5} ‘Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization -embryo transfer cycles with long gonadotropin -releasing hormone agonist’. J S Younis , M Matilsky , O Radin , Ben . \textit{Fertil Steril} 2001. 76 p. . \bibitem[Adashi et al. ()]{b10}\label{b10} ‘Insulin-like growth factors are intraovarian regulators of granulosa cell growth and functions’. E Y Adashi , C E Resnick , D 'ercol E , A J Svoboda , M E Van Wyk , JJ . \textit{Endocr Rev} 1985. 6 p. . \bibitem[Venetis et al. ()]{b4}\label{b4} ‘Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with probability of pregnancy in in vitro fertilization? A Survey Review And Meta-analysis’. C A Venetis , E M Kolibianakis , E Papinkalaou . \textit{Hum Reprod} 2007. 13 p. . \bibitem[Cedars et al. ()]{b9}\label{b9} ‘Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval’. M I Cedars , E Surey , F Hamiton , P Lapolt , D R Meldrum . \textit{Fertil Steril} 1990. 53 p. . \bibitem[Schoolcraft et al. ()]{b6}\label{b6} ‘Lower pregnancy rate with premature luteinization during pituitary suppression with luperolide acetate’. W Schoolcraft , E Sinton , T Schlenker , D Huvnh , F Hamiton , D R Meldrum . \textit{Fertil Steril} 1991. 55 p. . \bibitem[Serafini et al. ()]{b7}\label{b7} ‘Occurrence of spontaneous luteinizing hormone surge in superovulated cycle predictive value of serum progesterone’. P Serafini , B Stone , J Kerin , J Batzofin , P Quinn , R P Marrs . \textit{Fertil Steril} 1988. 49 p. 86. \bibitem[Ubaldi et al.]{b15}\label{b15} \textit{Premature leutinization in in vitro fertilization cycles using GnRH agonist \&}, F Ubaldi , M Camus , Smitz J , H C Bennink , A Van Steirteghem , P Devroey . \bibitem[Legro et al. ()]{b3}\label{b3} ‘Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in vitro fertilization’. R S Legro , B A Ary , R J Paulson , F Z Stanczyk , M V Sauer . \textit{Hum Reprod} 1993. 8 p. . \bibitem[Fleming ()]{b18}\label{b18} ‘Progesterone elevation on the day of hCG: Methodological issues’. R Fleming . \textit{Hum Reprod} 2008. 14 p. . \bibitem[recombinant follicle stimulating hormone & GnRHa & urinary FSH Fertil Steril ()]{b17}\label{b17} ‘recombinant follicle stimulating hormone \& GnRHa \& urinary FSH’. \textit{Fertil Steril} 1996. 66 p. . \bibitem[Huang et al. ()]{b1}\label{b1} ‘Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization’. K E Huang , E K Muechler , K E Schwarz , M Goggin , M C Graham . \textit{Fertil steril} 1986. 46 p. 903. \bibitem[Silverberg et al. ()]{b13}\label{b13} ‘Serum progesterone levels predict success in in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins’. K M Silverberg , W N Burns , D L Olive , R M Riehl , R S Schenken . \textit{J Clin Endocrinol Metab} 1991. 73 p. . \bibitem[Harper ()]{b23}\label{b23} ‘The implantation window’. M J Harper . \textit{Baillieres Clin Obstet Gynaecol} 1992. 6 (2) p. . \bibitem[Levy et al. ()]{b14}\label{b14} ‘The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome’. M J Levy , D B Smotrich , E A Widra , A W Sagoskin , D L Murray , J L Hall . \textit{J Assist Reprod Genet} 1995. 12 (3) p. . \end{bibitemlist} \end{document}